These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1833309)

  • 1. Production and characterization of a monoclonal antibody to the v-mos oncogene protein.
    Ishikawa K; Kurata N; Aoki H; Kato T; Marunouchi T
    Hybridoma; 1991 Jun; 10(3):357-68. PubMed ID: 1833309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
    Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
    Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functions of the mos oncogene family and associated gene products.
    Bold RJ; Hannink M; Donoghue DJ
    Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.
    Singh B; Stocking C; Walker R; Yang YD; Ostertag W; Arlinghaus RB
    J Virol; 1992 Feb; 66(2):1267-72. PubMed ID: 1309903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The physical interactions between p37env-mos and tubulin structures.
    Bai W; Singh B; Yang Y; Ramagli LS; Nash M; Herzog NK; Arlinghaus RB
    Oncogene; 1992 Mar; 7(3):493-500. PubMed ID: 1532247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for somatic cell expression of the c-mos protein [corrected].
    Herzog NK; Ramagli LS; Khorana S; Arlinghaus RB
    Oncogene; 1989 Nov; 4(11):1307-15. PubMed ID: 2530484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P55 protein affected by v-mos expression is vimentin.
    Singh B; Goldman R; Hutton L; Herzog NK; Arlinghaus RB
    J Virol; 1987 Nov; 61(11):3625-9. PubMed ID: 2822968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. v-mos protein produced by in vitro translation has protein kinase activity.
    Herzog NK; Nash M; Ramagli LS; Arlinghaus RB
    J Virol; 1990 Jun; 64(6):3093-6. PubMed ID: 2159564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
    Ohuchi T; Kurita Y; Sasai H; Miyoshi J; Nomura T; Toyoshima K
    Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the protein product of the c-mos proto-oncogene in mouse testes.
    Herzog NK; Singh B; Elder J; Lipkin I; Trauger RJ; Millette CF; Goldman DS; Wolfes H; Cooper GM; Arlinghaus RB
    Oncogene; 1988 Aug; 3(2):225-9. PubMed ID: 2970613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product.
    Schönthal A; Feramisco JR
    New Biol; 1990 Feb; 2(2):143-50. PubMed ID: 2150599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ; Marx M; Calothy G; Blair DG
    Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human and viral ets genes in E. coli production of human ets-2-specific monoclonal antibodies.
    Seth A; Watson DK; Fujiwara S; Showalter SD; Papas TS
    Oncogene Res; 1989; 5(1):61-6. PubMed ID: 2674859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for interaction between v-Mos and a p34cdc2 isoform, p35cdk.
    Bai W; Singh B; Yang Y; Arlinghaus RB
    Oncogene; 1992 Sep; 7(9):1757-63. PubMed ID: 1323818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the v-Mos oncogene in male meiotic germ cells of transgenic mice results in metaphase arrest.
    Rosenberg MP; Aversa CR; Wallace R; Propst F
    Cell Growth Differ; 1995 Mar; 6(3):325-36. PubMed ID: 7794800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and characterization of v-mos-activated transformation-associated proteins.
    Chan JC; Scanlon M; Zhang HZ; Jia LB; Yu DH; Hung MC; French M; Eastman EM
    J Biol Chem; 1992 Jan; 267(2):1099-103. PubMed ID: 1370458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of activated and normal mouse Mos gene in murine 3T3 cells.
    Paules RS; Resnick J; Kasenally AB; Ernst MK; Donovan P; Vande Woude GF
    Oncogene; 1992 Dec; 7(12):2489-98. PubMed ID: 1461652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of c-mos proto-oncogene transcripts in mouse tissues.
    Propst F; Vande Woude GF
    Nature; 1985 Jun 6-12; 315(6019):516-8. PubMed ID: 4000280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene.
    Seth A; Vande Woude GF
    J Virol; 1985 Oct; 56(1):144-52. PubMed ID: 2993645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific distribution of an epididymal 50 kDa protein revealed by an anti-Mos protein monoclonal antibody.
    Koyama Y; Ishikawa K; Marunouchi T
    Mol Reprod Dev; 1992 May; 32(1):62-6. PubMed ID: 1387541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.